Newsroom

Fungi are considered a natural source of antimicrobials in drug discovery. So far, little research has been done on the fungal diversity of tropical regions which promises novel compounds with antibiotic activity. An international research group led by Prof Marc Stadler from the Helmholtz Centre for Infection Research (HZI) has discovered novel metabolites that displayed antimicrobial and nematicidal responses. These substances are produced by a previously unknown type of fungus, which the team discovered during their study in the rainforest of Thailand. Results of their study were published in the scientific journal MycoKeys.

"Infections and Drugs" is one of four research topics of the Technische Universität Braunschweig. This positions TU Braunschweig as a close partner of the HZI. Their cooperation was the basis of the Systems Biology Centre BRICS that was established jointly in 2011. In an InFact interview, BRICS speaker Dieter Jahn, who is a professor of microbiology, explains how the TU Braunschweig and the HZI may benefit from each other in the long term.

Stroke and heart attack are the leading cause of death in the Western world. Würzburg scientists have used a special technique to get a clearer picture of the cells involved and their activity. They present their results in the journal Circulation Research.

Humans are constantly exposed to pathogens like bacteria and viruses. In most cases, the immune system successfully detects and eliminates these invaders. However, the herpesvirus family has adapted brilliantly to the immune system: its members manage to stay in the host’s body for life after infection. A research team at the Helmholtz Centre for Infection Research (HZI) recently discovered that a protein of the carcinogenic Kaposi’s sarcoma-associated herpesvirus (KSHV) commandeers an immune system component for its own benefit. This enables the virus to successfully infect its host. The researchers have published their results in the peer-reviewed journal PLOS Pathogens.

Pseudomonas aeruginosa bacteria are hospital germs and are often resistant to common antibiotics. They can infect all human organs and implants, and can persist in the body for long periods of time in a densely agglomerated community – a so-called biofilm. Agglomeration in the biofilm protects them from the immune system and even shields them from the effect of antibiotics. Scientists of the Helmholtz Institute for Pharmaceutical Research Saarland (HIPS) recently developed a molecule that suppresses the production of biofilms by Pseudomonas. The molecule has another crucial benefit: Due to its small size, it is suitable for oral intake, unlike other drugs of this type. The scientists published their results in Journal of the American Chemical Society. The editors of the journal selected the article as their lead story because of the significance of its findings ("Editor's Choice"). The selection was associated with free-of-charge publication and free access ("Open Access"). The HIPS is a branch of the Helmholtz Centre for Infection Research (HZI), operated in cooperation with the Saarland University and, being a part of the HZI, also is part of the German Center for Infection Research (DZIF).